About Index Trending news
Analyze
Pricing
CEVEC Pharmaceuticals

CEVEC Pharmaceuticals

Work at CEVEC Pharmaceuticals? Add yourself to this profile

CEVEC Pharmaceuticals

CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.
Edit Profile
More info

Elsewhere

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Venture capital
$8,628,000
Venture capital (Series B)
$5,400,000
Employees

Team size

10+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CEVEC Pharmaceuticals makes some noise.